GlobeNewswire by notified

Norway makes fishing vessel data accessible to the world

Share

Norway to become first European nation to share its vessel tracking information on Global Fishing Watch map

Lisbon, Portugal, June 30, 2022 (GLOBE NEWSWIRE) -- Norway has become the first country in Europe to partner with Global Fishing Watch—an international nonprofit organization dedicated to advancing ocean governance through increased transparency—and will share its vessel tracking data for the Norwegian fishing fleet on the organization’s public map

The announcement was made at the second United Nations Ocean Conference in Lisbon, Portugal where countries from around the world are gathering to mobilize action and innovative solutions to some of the ocean’s most pressing threats. 

Under the memorandum of understanding, which was signed between Global Fishing Watch and Norway’s Directorate of Fisheries, Norway has agreed to share the vessel monitoring system data for vessels 15 meters or more in length on the Global Fishing Watch map.

“Wild living marine resources are a common good and belong to everyone,” said Frank Bakke-Jensen, director general of the Directorate of Fisheries in Norway. “When a commercial fishing fleet is licensed to utilize this common good, we are obliged and committed to share fisheries data documenting the environmental footprint of commercial fishing activity. We hope that others will follow this approach and share more fisheries data.” 

“We believe that improved transparency of fishing data is necessary to reduce the risk of illegal fisheries and set the groundwork for improved compliance,” said Thord Monsen, head of monitoring, control and surveillance at the Directorate of Fisheries.

The incorporated data will span a total of approximately 600 vessels—all vessels 15 meters in length or more predominantly operating in Norwegian waters and the northeast Atlantic Ocean. Norway is currently expanding its VMS requirement to include all commercial fishing vessels, as well as increasing the frequency that vessels need to report their position—a requirement which will be implemented over the coming years in a phased approach. 

“We’re seeing more and more countries embrace fisheries transparency, demonstrating their understanding of just how essential public data is to the effective management of fishing activity,” said Tony Long, chief executive officer of Global Fishing Watch. “Norway has taken a leading global role in the sustainable ocean economy and is using its experience and expertise to promote better ocean governance. By bringing its fishing fleet into our map, Norway is paving the way for other countries, including developed nations, to follow suit.”

Since October 2019 Norway has shared its VMS tracking information on the Fisheries Directorate website in support of transparency and as part of an effort to make government data public whenever possible. The partnership with Global Fishing Watch will help make its vessel tracking data more accessible to a wider range of stakeholders—a substantial benefit in the sphere of international fisheries management. 

With a coastline of more than 83,000 kilometers, including islands and fjords, the fishing sector is a key element to Norway’s economic, social and cultural identity. Norway is the second largest exporter of fish and fish products by value in the world and is home to some of the most productive marine areas in the world. An influential voice when it comes to fisheries issues and a leader on blue economy issues, Norway’s decision to partner with Global Fishing Watch and amplify its vessel tracking data demonstrates how fisheries transparency can be adopted in countries where fishing represents such a significant part of the economy. 

“Data can be a powerful tool in protecting the environment, as we have seen in our work on climate change. The more data we have about the ocean, the better we can protect it and the people that rely on it. Norway's commitment to making fishing vessel data accessible to the world - via Global Fishing Watch - is a great step forward for ocean transparency," said Michael R. Bloomberg, Founder of Bloomberg Philanthropies and ​UN Special Envoy on Climate Ambition and Solutions. “Their commitment to data-sharing is a model other countries can follow, and it will help demonstrate the effectiveness - environmentally and economically - of sustainable fishing.”

Norway joins a growing number of progressive countries from around the world that are dedicated to advancing, and benefiting from, fisheries transparency, which include: Benin, Brazil, Belize, Chile, Costa Rica, Ecuador, Panama, Peru and the Republic of the Marshall Islands. 

Global Fishing Watch is an international nonprofit organization dedicated to advancing ocean governance through increased transparency of human activity at sea. By creating and publicly sharing map visualizations, data and analysis tools, we aim to enable scientific research and transform the way our ocean is managed. We believe human activity at sea should be public knowledge in order to safeguard the global ocean for the common good of all. globalfishingwatch.org

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)16.4.2024 23:30:00 CEST | Press release

SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva SELARSDI is expected to be marketed in the U.S. on or after February 21, 2025, following a settlement agreement with Johnson & Johnson, the manufacturer of StelaraSELARSDI was developed and is manufactured by Alvotech using murine cell (Sp2/0) and a continuous perfusion process, which are the same type of cells and process used for the production of Stelara REYKJAVIK, ICELAND & PARSIPPANY, NJ — Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients 6 years and older. Unde

Atico Reports Consolidated Financial Results for 202316.4.2024 22:30:29 CEST | Press release

(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) today announced its financial results for the year ended December 31, 2023, posting income from mining operations of $7.4 million and a net loss of $5.8 million. Production for the year at Atico’s El Roble mine totaled 13.2 million pounds (“lbs”) of copper and 10,149 ounces (“oz”) of gold in concentrate at a cash cost(1) of $2.04 per payable pound of copper(2). Fernando E. Ganoza, CEO and Director, commented, "we had a challenging year overall, with the first half of the year facing lower than expected head grades and lower throughput due to mechanical and operational issues, coupled with a significant appreciation in the Colombian Peso throughout the year which materially increased our costs. Despite these challenges the team did a great job getting El Roble mine back on track in the

Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program16.4.2024 22:10:00 CEST | Press release

Due to the broad diversity in the UV1 Phase II program and the encouraging results from previous UV1 trials, Ultimovacs remain confident in UV1’s potential and are strongly committed to bringing the company across the next important data points: The readout from FOCUS in Q3 2024 and DOVACC results in H1 2025Activity level adjustments and operational prioritization are implemented to sustain the financial runway, including a workforce reduction of approximately 40% The operational adjustment plan extends the anticipated cash runway to the fourth quarter of 2025, through the readout from the Phase II DOVACC trial Oslo, April 16, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announces a plan to optimize its business operations to support the continuous advancement of UV1 and long-term business growth. “We remain dedicated to our investigation of the potential impact of UV1 vaccine across several c

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations16.4.2024 22:05:00 CEST | Press release

ASPIRE-FTD Sites in the EU and U.S. to Use ClearPoint® Navigation Together With SmartFlow® Cannula for Intrathalamic Gene Therapy Administration SOLANA BEACH, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today congratulates its partner AviadoBio on treating its first patient in the ASPIRE-FTD Phase 1/2 clinical trial evaluating its investigational gene therapy AVB-101 in people with frontotemporal dementia (FTD) with progranulin (GRN) mutations. “FTD is an important cause of dementia in people under 65 and has a devastating impact on patients and families. The importance of accurately delivering this one-time gene therapy to the thalamus, while minimizing systemic exposure, is the precise use case of ClearPoint’s minimally invasive platform for gene and cell delivery,” stated Jeremy Stigall, Chief Business Officer at ClearPoin

Nokia Corporation: Repurchase of own shares on 16.04.202416.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 16 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 16.04.2024 Espoo, Finland – On 16 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL557,6403.17CEUX--BATE--AQEU--TQEX--Total557,6403.17 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

HiddenA line styled icon from Orion Icon Library.Eye